Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
OSU creates a digital twin of 26,000 trees across Elliot State Forest with the help of Scalable Display Technologies.
Mar. 5, 2026 A sweeping new ALMA image has peeled back the veil on the Milky Way’s core, exposing a dense network of cold gas filaments near the central black hole. Stretching across 650 light-years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results